Abstract
Papain and α-chymotrypsin were used for the protease-catalyzed assembly ofBoc-protected eledoisin (6−11)-hexapeptide by (2+4)- and (3+3)-segment condensation, respectively, in aqueous-organic solvent systems. As C-components, chemically synthesizedBoc-protected peptide methyl esters were employed. The nucleophilic tetrapeptide amide was prepared by papain-catalyzed (2+2)-segment coupling, while theZ-protected C-terminal dipeptide amide could be obtained by α-chymotrypsin- and thermolysin-catalyzed peptide bond formation. In addition, the influence of various reaction conditions, such as solvent composition, nucleophile concentration and reaction time, on the yield of theBoc-protected eledoisin (6−11)-hexapeptide was determined.
Similar content being viewed by others
Literatur
Fruton J. S., Adv. Enzymol.53, 239 (1982).
Jakubke H.-D., Kuhl P., Pharmazie37, 89 (1982).
Chaiken I. M., Komoriya A., Ohno M., Widmer F., Appl. Biochem. Biotechnol.7, 385 (1982).
Bozler H., Wayne S. I., Fruton J. S., Int. J. Peptide Protein Res.20, 102 (1982).
Wayne S. I., Fruton J. S., Proc. Natl. Acad. Sci. U.S.A.80, 3241 (1983).
Petkov D. D.,Stoineva I., Arch. Biochem. Biophys., im Druck.
Kullmann W., J. Biol. Chem.255, 8234 (1980).
Kullmann W., J. Biol. Chem.256, 1301 (1981).
Widmer F., Breddam K., Johansen J. T., in: Peptides 1980 (Brunfeldt K., Hrsg.), S. 46. Copenhagen: Scriptor. 1981.
Widmer F., Breddam K., Johansen J. T., Carlsberg Res. Commun.45, 453 (1980).
Isowa Y., Ohmori M., Sato M., Mori K., Bull. Chem. Soc. Japan50, 2766 (1977).
Takai H., Sakato K., Nakamizo N., Isowa Y., in: Peptide Chemistry 1980 (Okawa K., Hrsg.), S. 213. Osaka: Protein Research Foundation. 1981.
Kullmann W., Proc. Natl. Acad. Sci. U.S.A.79, 2840 (1982).
Kullmann W., J. org. Chemistry47, 5300 (1982).
Isowa Y.,Nagasawa T.,Kuroiwa K.,Narita K., Schwz. Pat. 597158, 31. März 1978, ref.: C.A.89, 24823 (1978).
Bertaccini G., Pharmacol. Rev.28, 127 (1976).
Bergmann J., Bienert M., Niedrich H., Mehlis B., Oehme P., Experientia30, 401 (1974).
Kuhl P., Döring G., Jakubke H.-D., Pharmazie38, 371 (1983).
Oka T., Morihara K., J. Biochem.82, 1055 (1977);Morihara K., Oka T., in: Peptide Chemistry 1977 (Shiba T., Hrsg.), S. 79, Proc. 15th Symp. on Peptide Chemistry, Protein Research Foundation, Osaka, 1978.
Döring G., Kuhl P., Jakubke H.-D., Monatsh. Chem.112, 1165 (1981).
Schnabel K., Liebigs Ann. Chem.702, 188 (1967).
Taschner E., Wasielewski C., Liebigs Ann. Chem.640, 136 (1961).
Author information
Authors and Affiliations
Additional information
Abkürzungen: Es wurden die IUPAC/IUB-Regeln für Aminosäure- und Peptidderivate befolgt; vgl. Eur. J. Biochem.53, 1 (1975). Die verwendeten Aminosäuren hatten mit Ausnahme von GlycinL-Konfiguration.Boc=tetr-Butyloxycarbonyl-,Z=Benzyloxycarbonyl-,Ac=Acetyl-, −OMe=Methylester.
Rights and permissions
About this article
Cite this article
Kuhl, P., Döring, G., Neubert, K. et al. Synthese von N-geschütztem Eledoisin (6–11)-Hexapeptid unter Verwendung von Proteasen als Biokatalysatoren. Monatsh Chem 115, 423–430 (1984). https://doi.org/10.1007/BF00810003
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00810003